Volume 67 Received 15 December 2010 | ||||||||||
| ||||||||||
aDepartamento de Química Orgánica, Facultad de Química, Pontificia Universidad Católica de Chile, 702843 Santiago de Chile, Chile, and bDepartamento de Química Inorgánica, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain
Correspondence e-mail: cosalas@puc.cl
The title compound, C26H28O3Si, is an allylic oxidation product of the tert-butyl(2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)diphenylsilane with N-bromosuccinimide and 2,2'-azobis-isobutyronitrile. The nine-atom bicyclic system is almost planar, with an r.m.s deviation of 0.0123 (2) Å and a maximum deviation of 0.031 (2) Å for the O atom. In the crystal, the molecules pile up along the b axis but the strongest intermolecular contacts are the
-
stacking interactions between the benzene rings along the c axis [centroid-centroid distance = 3.655 (3) Å].
Benzofuranones are precursors of a wide range of natural and synthetic products. For a related transformation of benzofuranones in aurones, see: Schoepfer et al. (2002
); Löser et al. (2004
); in spiroannulated and aromatic spiroketal compounds, see: Braun et al. (2008
); Zhou et al. (2008
); in benzofurane derivatives, see: Venkatesan et al.(2010
); and in pyranobenzofuranes, see: Foroumadi et al. (2009
).
|
Data collection: SMART (Bruker, 2007
); cell refinement: SAINT (Bruker, 2007
); data reduction: SAINT; program(s) used to solve structure: SIR97 (Altomare et al., 1999
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997
); software used to prepare material for publication: WinGX (Farrugia, 1999
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SI2320 ).
We gratefully acknowledge the Unidade de Raios X, RIAIDT, University of Santiago de Compostela, Spain.
Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.
![[details]](../../../../../../j/graphics/details.gif)
Braun, M., Hessamian-Alinejad, A., de Lacroix, B. F., Álvarez, B. H. & Fischer, G. (2008). Molecules, 13, 995-1003.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Bruker (2001). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Bruker (2007). SMART and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[details]](../../../../../../j/graphics/details.gif)
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.
![[details]](../../../../../../j/graphics/details.gif)
Foroumadi, A., Zamanian, S., Samzadeh-Kermani, A. & Shafiee, A. (2009). Synth. Commun. 39, 1722-1728.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Löser, R., Chlupacova, M., Marecek, A., Opletanova, V. & Gütschow, M. (2004). Helv. Chim. Acta, 87, 2597-2601.
Schoepfer, J., Fretz, H., Chaudhuri, B., Muller, L., Seeber, E., Meijer, L., Lozach, O., Vangrevelinghe, E. & Furet, P. (2002). J. Med. Chem. 45, 1741-1747.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Venkatesan, A. M., Dos Santos, O., Ellingboe, J., Edvard, D. A., Harrison, B. L., Smith, D. L., Scerni, R., Hornby, G. A., Schechter, L. E. & Andree, T. H. (2010). Bioorg. Med. Chem. 20, 824-827. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Zhou, G., Zhu, J., Xie, Z. & Li, Y. (2008). Org. Lett. 10, 721-724.
![[ChemPort]](../../../../../../logos/chemportborder.gif)